What kind of device can be used to measure Maximum Inspiratory Pressure (MIP) and Maximum Expiratory Pressure (MEP) for a patient with Guillain Barre syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Devices for Measuring MIP and MEP in Guillain-Barré Syndrome

Use a hand-held digital pressure meter with a flanged mouthpiece, small leak system, and pressure transducer connected to a recording device for measuring MIP and MEP at the bedside in Guillain-Barré patients. 1

Primary Device Configuration

The standard measurement system consists of the following components:

  • Flanged mouthpiece (preferred over tube mouthpiece) with a three-way tap or valve system that allows normal breathing followed by maximal maneuvers 1
  • Small leak (approximately 2-mm internal diameter, 20-30 mm length) built into the system to prevent glottic closure during MIP measurement and reduce buccal muscle contribution during MEP measurement 1
  • Digital pressure transducer connected to a recording system that displays pressure in analog form or digitizes it for measurement 1
  • Hand-held pressure meters are specifically advantageous for bedside use in GBS patients, as they are portable and easily deployed in ICU settings 1

Critical Technical Specifications

The pressure transducer must be calibrated regularly against a fluid manometer with baseline pressure equal to atmospheric pressure 1. Avoid aneroid manometers as the analog dial is difficult to read accurately and pressure transients are difficult to eliminate 1. Mercury manometers should be avoided for safety reasons 1.

The system must allow pressure to be maintained for at least 1.5 seconds so that maximum pressure sustained for 1 second can be recorded, as peak pressure may be higher but less reproducible 1.

Measurement Technique for GBS Patients

  • Position the patient seated (if possible) without noseclips 1
  • Perform MIP measurements at or near residual volume (RV) using the Mueller maneuver 1
  • Perform MEP measurements at or near total lung capacity (TLC) using the Valsalva maneuver 1
  • Coach patients to prevent air leaks around the mouthpiece and support their cheeks during expiratory efforts by pinching lips around the mouthpiece 1
  • Record the maximum value of three maneuvers that vary by less than 20% 1

GBS-Specific Monitoring Context

In Guillain-Barré syndrome, these measurements are part of the "20/30/40 rule" for respiratory failure risk: vital capacity <20 mL/kg, MIP <30 cmH₂O, or MEP <40 cmH₂O indicates imminent respiratory failure requiring intubation 1, 2, 3. Serial measurements every 2-4 hours are essential in patients with risk factors 2, 3.

Alternative Devices for Specific Situations

For mechanically ventilated GBS patients, measurement becomes more straightforward as the endotracheal tube bypasses the compliant upper airway, allowing rapid transmission of alveolar pressure changes to the airway opening 1, 4. A unidirectional valve system can be attached to the ventilator circuit to measure MIP by allowing exhalation while blocking inhalation, with highest values typically reached after 15-20 efforts or 15-20 seconds of airway occlusion 1, 4.

However, critical limitation: reproducibility of MIP/MEP in ventilated patients is poor, and true values are often significantly underestimated due to poor cooperation, making low values unreliable for clinical decisions 1, 4. In this scenario, prioritize vital capacity measurement and consider P0.1 (airway occlusion pressure at 0.1 second) as a more reliable alternative 4.

Cost-Effective Alternative

Non-clinical digital manometers (industrial devices) show high agreement with clinical digital manometers (ICC 0.998 for MIP, 0.999 for MEP) in healthy volunteers and may be considered where cost is prohibitive, though further validation at lower pressures in diseased populations is needed 5.

Complementary Measurement: Sniff Nasal Inspiratory Pressure

While not replacing standard MIP/MEP measurement, sniff nasal inspiratory pressure (SnPna) can be measured using the same pressure transducer system with a nasal plug. SnPna >-70 cmH₂O (males) or >-60 cmH₂O (females) suggests absence of significant weakness 2. Notably, SnPna was the only respiratory parameter that correlated closely with MRC Sum Score in acute GBS patients (r=0.77 on day 1, r=0.74 on day 7), while spirometry did not 6.

Common Pitfalls to Avoid

  • Do not rely solely on pulse oximetry or arterial blood gases as early indicators of respiratory failure in GBS, as these remain normal until late-stage failure 2, 3
  • Do not use aneroid or mercury manometers due to poor accuracy and safety concerns 1
  • Recognize that MIP/MEP measurements require significant patient cooperation, which may be compromised in GBS patients with bulbar dysfunction, dysautonomia, or altered mental status 4, 7
  • Understand that MIP provides poor additional information beyond vital capacity in acute respiratory muscle failure, as the relationship between VC and MIP is linear rather than curvilinear 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Respiratory Management in Guillain-Barré Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Respiratory Failure Prediction in Guillain-Barré Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ventilator Measurements in Mechanically Ventilated GBS Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.